Solos Endoscopy Inc (SNDY) 0.0080 $SNDY Solos E
Post# of 273254
Posted On: 09/22/2016 3:22:04 PM
Solos Endoscopy Inc (SNDY) 0.0080 $SNDY
Solos Endoscopy, Inc. Completes Capital Restructuring Initiative
ACCESSWIRE - Thu Sep 24, 10:56AM CDT
BOSTON, MA / ACCESSWIRE / September 24, 2015 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY) (OTC Pink: SNDYD) (PINKSHEETS: SNDYD), a provider of quality innovative healthcare instruments to hospitals across the country, is pleased to announce that the company has completed a capital restructuring initiative as part of a previously announced recapitalization plan in order to position itself for growth over the next twelve months. The restructuring involved a common stock consolidation that took effect September 23, 2015. As a result of this announcement, the stock symbol will be changed temporarily to SNDYD for a period of 20 business days after September 23, 2015.
MammoView System Utilized in Live Ductoscopy Demonstration at the Dr. Susan Love Research Foundation Symposium on the Breast
eTeligis - Tue Apr 14, 12:23AM CDT
BOSTON, MA, United States, via ETELIGIS INC., 04/09/2015 - -
Solos Endoscopy's MamoView(R) to Participate at the Dr. Susan Love Research Foundation Symposium on the Breast
ACCESSWIRE - Mon Nov 24, 9:56AM CST
BOSTON, MA / ACCESSWIRE / November 24, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that it has been invited to participate at the 8th International Dr. Susan Love Research Foundation Symposium on the Breast.
Solos Endoscopy's MamoView(R) Demonstrates Strong Growth Potential
ACCESSWIRE - Wed Nov 12, 9:29AM CST
BOSTON, MA / ACCESSWIRE / November 12, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, is pleased to announce that the company's MamoView(R) Breast Endoscopy System has shown strong growth over the past 18 months. Solos management has reported that MamoView(R) product sales has increased as a percentage of gross sales and in the past 18 months the company has received more than $300,000 in MamoView(R) orders from hospitals nationwide.
Solos Endoscopy Successfully Completes ISO Certification Annual Audit by TUV SUD America
ACCESSWIRE - Wed Oct 08, 9:58AM CDT
BOSTON, MA / ACCESSWIRE / October 8, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the country, is pleased to announce that the company has successfully completed the annual audit for its ISO 13485:2003 Certification from TUV SUD America. The Certification to ISO 13485:2003 allows Solos Endoscopy to place the CE Mark on the majority of the company's endoscopic instruments including the MammoView(R) devices.
Solos Endoscopy, Inc. Completes Capital Restructuring Initiative
ACCESSWIRE - Thu Sep 24, 10:56AM CDT
BOSTON, MA / ACCESSWIRE / September 24, 2015 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY) (OTC Pink: SNDYD) (PINKSHEETS: SNDYD), a provider of quality innovative healthcare instruments to hospitals across the country, is pleased to announce that the company has completed a capital restructuring initiative as part of a previously announced recapitalization plan in order to position itself for growth over the next twelve months. The restructuring involved a common stock consolidation that took effect September 23, 2015. As a result of this announcement, the stock symbol will be changed temporarily to SNDYD for a period of 20 business days after September 23, 2015.
MammoView System Utilized in Live Ductoscopy Demonstration at the Dr. Susan Love Research Foundation Symposium on the Breast
eTeligis - Tue Apr 14, 12:23AM CDT
BOSTON, MA, United States, via ETELIGIS INC., 04/09/2015 - -
Solos Endoscopy's MamoView(R) to Participate at the Dr. Susan Love Research Foundation Symposium on the Breast
ACCESSWIRE - Mon Nov 24, 9:56AM CST
BOSTON, MA / ACCESSWIRE / November 24, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that it has been invited to participate at the 8th International Dr. Susan Love Research Foundation Symposium on the Breast.
Solos Endoscopy's MamoView(R) Demonstrates Strong Growth Potential
ACCESSWIRE - Wed Nov 12, 9:29AM CST
BOSTON, MA / ACCESSWIRE / November 12, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, is pleased to announce that the company's MamoView(R) Breast Endoscopy System has shown strong growth over the past 18 months. Solos management has reported that MamoView(R) product sales has increased as a percentage of gross sales and in the past 18 months the company has received more than $300,000 in MamoView(R) orders from hospitals nationwide.
Solos Endoscopy Successfully Completes ISO Certification Annual Audit by TUV SUD America
ACCESSWIRE - Wed Oct 08, 9:58AM CDT
BOSTON, MA / ACCESSWIRE / October 8, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the country, is pleased to announce that the company has successfully completed the annual audit for its ISO 13485:2003 Certification from TUV SUD America. The Certification to ISO 13485:2003 allows Solos Endoscopy to place the CE Mark on the majority of the company's endoscopic instruments including the MammoView(R) devices.
(0)
(0)Scroll down for more posts ▼